Moreover, circCRIM1 significantly promoted the progression of HCC via sponging miR-378a-3p and targeting SKP2.Therefore, circCRIM1 can be regarded as a prognostic biomarker and a possible therapeutic target for some patients with HCC. This evidence concerns the gene SKP2 and hepatocellular carcinoma.